Expanding Treatment Options for Metastatic Prostate Cancer

被引：70

作者：

Antonarakis, Emmanuel S. ^{[1
]}

Eisenberger, Mario A. ^{[1
]}

机构：

[1] Johns Hopkins Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2011年 / 364卷 / 21期

关键词：

MITOXANTRONE PLUS PREDNISONE; TRIAL;

D O I：

10.1056/NEJMe1102758

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2055 / 2058

页数：4

共 10 条

[1] The changing face of low-risk prostate cancer: Trends in clinical presentation and primary management [J].

Cooperberg, MR ;

Lubeck, DP ;

Meni, MV ;

Mehta, SS ;

Carroll, PR .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) :2141-2149

[2] Abiraterone and Increased Survival in Metastatic Prostate Cancer [J].

De Bono, Johann S. ;

Logothetis, Christopher J. ;

Molina, Arturo ;

Fizazi, Karim ;

North, Scott ;

Chu, Luis ;

Chi, Kim N. ;

Jones, Robert J. ;

Goodman, Oscar B., Jr. ;

Saad, Fred ;

Staffurth, John N. ;

Mainwaring, Paul ;

Harland, Stephen ;

Flaig, Thomas W. ;

Hutson, Thomas E. ;

Cheng, Tina ;

Patterson, Helen ;

Hainsworth, John D. ;

Ryan, Charles J. ;

Sternberg, Cora N. ;

Ellard, Susan L. ;

Flechon, Aude ;

Saleh, Mansoor ;

Scholz, Mark ;

Efstathiou, Eleni ;

Zivi, Andrea ;

Bianchini, Diletta ;

Loriot, Yohann ;

Chieffo, Nicole ;

Thian Kheoh ;

Haqq, Christopher M. ;

Scher, Howard I. .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (21) :1995-2005

[3] Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial [J].

de Bono, Johann Sebastian ;

Oudard, Stephane ;

Ozguroglu, Mustafa ;

Hansen, Steinbjorn ;

Machiels, Jean-Pascal ;

Kocak, Ivo ;

Gravis, Gwenaelle ;

Bodrogi, Istvan ;

Mackenzie, Mary J. ;

Shen, Liji ;

Roessner, Martin ;

Gupta, Sunil ;

Sartor, A. Oliver .

LANCET, 2010, 376 (9747) :1147-1154

[4] Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study [J].

Fizazi, Karim ;

Carducci, Michael ;

Smith, Matthew ;

Damiao, Ronaldo ;

Brown, Janet ;

Karsh, Lawrence ;

Milecki, Piotr ;

Shore, Neal ;

Rader, Michael ;

Wang, Huei ;

Jiang, Qi ;

Tadros, Sylvia ;

Dansey, Roger ;

Goessl, Carsten .

LANCET, 2011, 377 (9768) :813-822

[5] Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer [J].

Hu, Rong ;

Dunn, Thomas A. ;

Wei, Shuanzeng ;

Isharwal, Sumit ;

Veltri, Robert W. ;

Humphreys, Elizabeth ;

Han, Misop ;

Partin, Alan W. ;

Vessella, Robert L. ;

Isaacs, William B. ;

Bova, G. Steven ;

Luo, Jun .

CANCER RESEARCH, 2009, 69 (01) :16-22

[6] Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer. [J].

Kantoff, Philip W. ;

Higano, Celestia S. ;

Shore, Neal D. ;

Berger, E. Roy ;

Small, Eric J. ;

Penson, David F. ;

Redfern, Charles H. ;

Ferrari, Anna C. ;

Dreicer, Robert ;

Sims, Robert B. ;

Xu, Yi ;

Frohlich, Mark W. ;

Schellhammer, Paul F. ;

Ahmed, T. ;

Amin, A. ;

Arseneau, J. ;

Barth, N. ;

Bernstein, G. ;

Bracken, B. ;

Burch, P. ;

Caggiano, V. ;

Chin, J. ;

Chodak, G. ;

Chu, F. ;

Corman, J. ;

Curti, B. ;

Dawson, N. ;

Deeken, J. F. ;

Dubernet, T. ;

Fishman, M. ;

Flanigan, R. ;

Gailani, F. ;

Garbo, L. ;

Gardner, T. ;

Gelmann, E. ;

George, D. ;

Godfrey, T. ;

Gomella, L. ;

Guerra, M. ;

Hall, S. ;

Hanson, J. ;

Israeli, R. ;

Jancis, E. ;

Jewett, M. A. S. ;

Kassabian, V. ;

Katz, J. ;

Klotz, L. ;

Koeneman, K. ;

Koh, H. ;

Kratzke, R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (05) :411-422

[7] Starving the Addiction: New Opportunities for Durable Suppression of AR Signaling in Prostate Cancer [J].

Knudsen, Karen E. ;

Scher, Howard I. .

CLINICAL CANCER RESEARCH, 2009, 15 (15) :4792-4798

[8] Antiandrogen withdrawal alone or in combination with ketoconazole in androgen-independent prostate cancer patients: A phase III trial (CALGB 9583) [J].

Small, EJ ;

Halabi, S ;

Dawson, NA ;

Stadler, WM ;

Rini, BI ;

Picus, J ;

Gable, P ;

Torti, FM ;

Kaplan, E ;

Vogelzang, NJ .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (06) :1025-1033

[9] Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: A Canadian randomized trial with palliative end points [J].

Tannock, IF ;

Osoba, D ;

Stockler, MR ;

Ernst, DS ;

Neville, AJ ;

Moore, MJ ;

Armitage, GR ;

Wilson, JJ ;

Venner, PM ;

Coppin, CML ;

Murphy, KC .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (06) :1756-1764

[10] Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer [J].

Tannock, IF ;

de Wit, R ;

Berry, WR ;

Horti, J ;

Pluzanska, A ;

Chi, KN ;

Oudard, S ;

Theodore, C ;

James, ND ;

Turesson, I ;

Rosenthal, MA ;

Eisenberger, MA .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (15) :1502-1512

← 1 →